Videos

Christine Seidman, MD, director of the cardiovascular genetics program, cardiovascular medicine specialist, Brigham & Women’s Hospital, discusses the use of genetics to crack the code of cardiovascular diseases to enable earlier prevention and interventions. She was named the winner of the American Heart Association (AHA) 2022 Research Achievement Award, AHA's highest honor.

VIDEO: Using genetics in cardiology to enable earlier interventions

Christine Seidman, MD, director of the cardiovascular genetics program at Brigham & Women’s Hospital, spoke to us about using genetics to crack the code of cardiovascular disease. 

Clyde W. Yancy, MD, MSc, vice dean for diversity and inclusion, chief of cardiology in the Department of Medicine, and a professor of medicine in cardiology and medical social sciences at Northwestern Medicine, discusses health equity issues in cardiology at the American Heart Association (AHA) 2022 meeting.

VIDEO: Health equity and diversity is a business model

Clyde Yancy, MD, vice dean for diversity and inclusion, chief of cardiology, and a professor of medicine in cardiology and medical social sciences at Northwestern Medicine, discusses health equity issues and how greater inclusion should be a business model because of changing demographics.

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

VIDEO: The importance of assessing TAVR valve durability

Brian Lindman, MD, discusses the tracking of TAVR devices for signs of deterioration and how to assess long-term durability.

Takeshi Tsuda, MD, pediatric cardiologist, Nemours Children’s Health, Delaware, discusses evaluation of cardio-toxicity in pediatric cancer patients. He presented a study at American Heart Association (AHA) 2022 meeting that hoped to show the use of cardiac stress testing on children would indicate which patients would see more toxicity from chemotherapy agents. #AHA #AHA22

VIDEO: Identifying cardiotoxicity in young cancer patients

Pediatric cardiologist Takeshi Tsuda, MD, discussed the evaluation of cardiotoxicity in young cancer patients at the American Heart Association (AHA) 2022 meeting.

VIDEO: The need to develop the cardiology workforce

ACC President Edward T.A. Fry, MD, explains the need to better develop the cardiology workforce as the subspecialty faces a looming shortage of cardiologists. 

Juan Granada discusses new cardiac technology AHA22.

VIDEO: 2 key technologies to rapidly advance cardiovascular care

Juan Granada, MD, president and CEO of the Cardiovascular Research Foundation (CRF), shares his thoughts on two key areas of technology advancements in cardiovascular imaging and neuro-interventional care for stroke.

Interview with the late-breaking BEST-CLI trial principal investigators Alik Farber from Boston Medical Center, Matthew Menard from Brigham and Women's Hospital, and Ken Rosenfield at Mass General Hospital, at the 2022 American Heart Association (AHA) meeting. The trial looked at endovascular versus bypass surgery in patients with critical limb ischemia (CLI) to see which is better. #AHA22

VIDEO: Surgery vs. endovascular intervention for critical limb ischemia in the BEST-CLI trial

Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial. 

Cian McCarthy, MD, cardiovascular fellow, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin. However, he expects that to rise because of high sensitivity troponin (hs-cTn) being included in recent guidelines as a front-line test.

VIDEO: High sensitivity cardiac troponin use based on the NCDR Chest Pain-MI Registry 

Cian McCarthy, MD, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.